CerebroSight™ DX
AI powered Non Contrast CT Brain Solution
Overview
CerebroSight™ DX is a cutting-edge Non-Contrast CT (NCCT) Brain AI-powered solution designed to assist radiologists in the rapid and accurate evaluation of acute brain conditions. Leveraging deep learning algorithms trained on large, diverse datasets, the module can detect and highlight critical pathology such as intracranial hemorrhage, ischemic stroke signs, edema, and mass effect—within seconds.
This AI-powered tool integrates seamlessly with ramOS AI platform, VNA / PACS and teleradiology workflows, automatically analyzing NCCT scans upon acquisition. It generates prioritized alerts, overlays, and quantified measurements, enabling faster clinical decision-making, especially in time-sensitive scenarios like stroke code activation.
Key Features
Automated Detection: Hemorrhage (intraparenchymal, subdural, epidural, subarachnoid), early ischemic changes, edema.
Triage & Prioritization: Flags urgent findings for immediate review.
Quantitative Insights: Hemorrhage volume estimation and midline shift measurements.
Seamless Integration: Works with ramOS AI platform, PACS, and enterprise imaging systems.
Key Benefits
- Faster Turnaround: Cuts reporting time by highlighting key findings instantly.
- High Accuracy: Reduces missed diagnoses and inter-observer variability.
- Structured Output: Delivers ready-to-review, standards-compliant reports.
- Scalable Integration: Works across enterprise imaging platforms and teleradiology setups.
- Clinical Impact: Supports early intervention, personalized treatment planning, and better patient outcomes.
By reducing turnaround time and minimizing diagnostic oversight, the NCCT Brain AI module empowers clinicians to deliver faster, more accurate care in critical neurological emergencies.